Swiss drugmaker Novartis said on Saturday it had received a binding offer from Germany’s Siemens Healthineers to acquire its molecular imaging business for Fluorine-18 positron emission tomography, or PET scans.
In a statement sent to Reuters, Novartis did not confirm the value of the deal but said Siemens Healthineers would remain a partner in the Novartis radioligand therapy business, adding that it expects the transaction to close in the fourth quarter.
ہم نے اس خبر کا خلاصہ کیا ہے تاکہ آپ اسے جلدی سے پڑھ سکیں۔ اگر آپ خبر میں دلچسپی رکھتے ہیں تو آپ مکمل متن یہاں پڑھ سکتے ہیں۔ مزید پڑھ:
پاکستان تازہ ترین خبریں, پاکستان عنوانات
Similar News:آپ اس سے ملتی جلتی خبریں بھی پڑھ سکتے ہیں جو ہم نے دوسرے خبروں کے ذرائع سے جمع کی ہیں۔
Siemens quarterly profit beats market view on electrification, softwareGerman industrial gear maker Siemens posted better-than-expected earnings growth during the April-to-June quarter, buoyed by customers who are upgrading...
ذریعہ: YahooFinanceCA - 🏆 47. / 63 مزید پڑھ »
Siemens quarterly profit beats market view on electrification, softwareGerman industrial gear maker Siemens posted better-than-expected earnings growth during the April-to-June quarter, buoyed by customers who are upgrading...
ذریعہ: YahooFinanceCA - 🏆 47. / 63 مزید پڑھ »
A German diaspora in North Carolina is booming thanks to a multibillion-dollar investment from Germany, but a potential Trump Presidency is causing anxietyThousands of Germans have flocked to North Carolina in recent years, aided by investments from Siemens and Daimler.
ذریعہ: YahooFinanceCA - 🏆 47. / 63 مزید پڑھ »